Literature DB >> 19771535

Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B.

Alessandro Allegra1, Giuseppa Penna, Andrea Alonci, Angela Granata, Arianna D'Angelo, Caterina Musolino.   

Abstract

Immune thrombocytopenia is a disease mediated by platelet autoantibodies that accelerate platelet destruction and inhibit their production. Most cases are considered idiopathic, whereas others are secondary to coexisting conditions such as infectious diseases. All hepatotropic viruses seem able to cause thrombocytopenia. The advent of molecular techniques has revealed the possible persistence of hepatitis B virus genome in HBsAg-negative individuals with or without serologic markers of previous infection. This form of infection is named occult. We report a case of autoimmune thrombocytopenia associated with acute reverse seroconversion of hepatitis B in a patient who was initially hepatitis B virus surface antigen negative and hepatitis B virus surface antibody positive. The search for occult HBV infection before immunosuppressive therapy and monitoring for reactivation is today diagnostic standard and several reports have been presented in literature about HBV reactivation following immunosuppressive therapy. In our patient, reactivation of dormant HBV happened prior to any immunosuppressive therapy. The case we report offers the occasion to emphasize the importance of medium-term and long-term hemovigilance also in other kind of patients than in subjects on immunosuppressive therapy. A deeper follow-up is advisable even in patients showing an unexplainable worsening of their hematological conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19771535     DOI: 10.1007/s12032-009-9305-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  14 in total

1.  What is the clinical impact of occult hepatitis B virus infection?

Authors:  Giovanni Raimondo; Teresa Pollicino; Giovanni Squadrito
Journal:  Lancet       Date:  2005 Feb 19-25       Impact factor: 79.321

2.  Childhood hepatitis E infection complicated by acute immune thrombocytopenia.

Authors:  Rajoo Thapa; Debkrishna Mallick; Apurba Ghosh
Journal:  J Pediatr Hematol Oncol       Date:  2009-02       Impact factor: 1.289

Review 3.  The ITP syndrome: pathogenic and clinical diversity.

Authors:  Douglas B Cines; James B Bussel; Howard A Liebman; Eline T Luning Prak
Journal:  Blood       Date:  2009-04-24       Impact factor: 22.113

4.  [Autoimmune thrombopenia associated with hepatitis B reactivation (reverse seroconversion) after autologous hematopoietic stem cell transplantation].

Authors:  Alexandre Aubourg; Louis d'Alteroche; Delphine Senecal; Catherine Gaudy; Yannick Bacq
Journal:  Gastroenterol Clin Biol       Date:  2007-01

5.  A case-control study of serious autoimmune adverse events following hepatitis B immunization.

Authors:  David A Geier; Mark R Geier
Journal:  Autoimmunity       Date:  2005-06       Impact factor: 2.815

6.  Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region.

Authors:  Kiyoshi Kitano; Hikaru Kobayashi; Mayu Hanamura; Kiyoshi Furuta; Mayumi Ueno; Akinori Rokuhara; Eiji Tanaka; Takeji Umemura; Kendo Kiyosawa
Journal:  Eur J Haematol       Date:  2006-09       Impact factor: 2.997

Review 7.  A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review.

Authors:  M R Geier; D A Geier
Journal:  Clin Exp Rheumatol       Date:  2004 Nov-Dec       Impact factor: 4.473

8.  Immune thrombocytopenic purpura as sole manifestation in a case of acute hepatitis A.

Authors:  Gönül Tanir; Cumhur Aydemir; Nilden Tuygun; Ozge Kaya; Neşe Yarali
Journal:  Turk J Gastroenterol       Date:  2005-12       Impact factor: 1.852

9.  Hepatitis B virus reactivation in a surface antigen-negative and antibody-positive patient after rituximab plus CHOP chemotherapy.

Authors:  Eui Bae Kim; Dae Sik Kim; Seh Jong Park; Yong Park; Kyoung Ho Rho; Seok Jin Kim
Journal:  Cancer Res Treat       Date:  2008-03-31       Impact factor: 4.679

10.  Occult hepatitis B virus in liver tissue of individuals without hepatic disease.

Authors:  Giovanni Raimondo; Giuseppe Navarra; Stefania Mondello; Lucy Costantino; Guido Colloredo; Eugenio Cucinotta; Gaetano Di Vita; Claudio Scisca; Giovanni Squadrito; Teresa Pollicino
Journal:  J Hepatol       Date:  2008-02-13       Impact factor: 25.083

View more
  1 in total

1.  Dexamethasone Stimulates Hepatitis B Virus (HBV) Replication Through Autophagy.

Authors:  Qiao He; Xiaoyu Song; Yecai Huang; Wenjuan Huang; Bo Ye; Huaichao Luo; Hao Luo; Lichun Wu; Zuo Wang; Weixian Chen; Li Zhang
Journal:  Med Sci Monit       Date:  2018-07-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.